Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-182-7 | CAS number: 135-19-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute toxicity of the test substance 2-naphthol via the oral route was evaluated during a study performed according to the OECD Testing Guideline 401 (Acute Oral Toxicity). The study was GLP compliant.
The fixed dose method was used. The following doses were investigated and administered by gavage.
1250 mg/kg bw: concentration in sesame oil: 25%, administration volume: 5 ml/kg b.w.
1600 mg/kg bw: concentration in sesame oil: 25%, administration volume: 6 and 4 ml/kg b.w.
2000 mg/kg bw: concentration in sesame oil: 25%, administration volume: 8 ml/kg b.w.
2500 mg/kg bw: concentration in sesame oil: 25%, administration volume: 10 ml/kg b.w.
Following exposure to the test substance, animals were observed for 14 days. Lethality occured until day 3 after administration. The following clinical signs were observed at the day of administration: decreased spontaneous activity, squatting position, prone/lateral position, irregular breathing, respiratory rales, narrowed palpebral fissure and bristled fur. In higher doses (as from 1600 mg/kw/bw) dizziness, tonic-clonic seizures and decreased position reflexes were observed. From day 1 after administration withdrawn flanks, blood clored incrusted muzzles and diarrhoea were observed. For one make animal in the 2500 mg/kg/bw group the position- and paw pinch-reflex was eliminated. For a female animal in the 2500 mg/kg/bw group no increase of body weight could be determined after 7 days. At the end of the test period, this animal considerably exceeded its initial weight. The development of body weight for the other animals was not affected. The macroscopic examination of the died male and female animals revealed the following characteristics: blood vessels of the gastrointestinal tract considerably injected - stomach and small intestine filled with substance remains - stomach inflated - clotted blood in small intestines - urinary bladder fillded with brownish-gloomy liquid. The animals killed at the end of the follow-up period were free of macroscopic visible changes.
Based on LD50 values of 1340 mg/kw/bw in female rats and 1300 mg/kg/bw in males rats, 2-naphthol was classified as harmful according to the CLP regulation.
The acute toxicity of the test substance 2-naphthol via the inhalation route was evaluated during a study performed according to the OECD Testing Guideline 403 (Acute Inhalation Toxicity). The study was GLP compliant.
Groups of 5 male and female Wistar rats were exposed for 4 hours to concentrations of 0.9, 1.94, 2.50, 5.06 mg/L (air) of 2-naphthol. The substance was aerosoled at 50% in polyethylene glycol 400 / ethanol (1:1).
Analysis were conducted during exposure to confirm the actual concentrations the animals were exposed to.
At the end of exposure, animals were observed for 14 days. Bodyweight and clinical signs were recorded. At the end of the observation period, surviving animals were necropsied.
All the animals exposed to the highest concentration of test substance in air were found dead by the end of the observation period. At 2.50 mg/L (air), 9/10 animals died as a result of the exposure. 1/10 animals exposed to 1.94 mg/L (air) of test substance for 4 hours was found dead. All the animals exposed to 0.90 mg/L (air) survived until the end of the observation period.
The animals showed irregular respiration, sonorous rales, panting, gasping, sneezing, narrowed palpebral fissures, stilted, uncoordinated and ataxic gait, ataxia, trembling, decreased spontaneous activity, sunken flanks, squatting posture, prone position, straddling hind limbs, forward crawling, ruffled and bristling coat, blood-coloured encrusted noses, blood coloured nasal discharge, stupor, sedation, reduced or absent pawreflex to pinching, reduced or no placing reflex, delayed or no corneal reflex, corneal opacity and diarrhea.
Body weight development was impaired during the first week. At the end of the study, all surviving animals had surpassed their initial weights.
At necropsy, changes were observed in the lungs of animals.
The 4h-LC50 was determined to be 2.20 mg/L (air) based on the deaths observed during the study. Since this value is between 1.0 and 5.0 mg/L (air), 2-naphthol meets the criteria for classification as Acute Tox. 4; H332 according to Regulation (EC) No.1272/2008.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 13.08.1986 - 10.09.1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 12.05.1981
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- age of the animals at the test beginning:
male rats: 7 weeks
female rats: 8 weeks - Route of administration:
- oral: gavage
- Vehicle:
- other: Oleum Sesami, Ph. Eur. III
- Details on oral exposure:
- 1250 mg/kg bw: concentration in sesame oil: 25%, administration volume: 5 ml/kg b.w.
1600 mg/kg bw: concentration in sesame oil: 25%, administration volume: 6 and 4 ml/kg b.w.
2000 mg/kg bw: concentration in sesame oil: 25%, administration volume: 8 ml/kg b.w.
2500 mg/kg bw: concentration in sesame oil: 25%, administration volume: 10 ml/kg b.w. - Doses:
- 1250 mg/kg bw, 1600 mg/kg bw, 2000 mg/kg bw, 2500 mg/kg bw
- No. of animals per sex per dose:
- 10 (5 male, 5 female)
- Control animals:
- not specified
- Details on study design:
- observation period after administration: 14 d
- Statistics:
- LD50, 95% CL and the equation of the probit straight line were determined via probit analysis from different lethality rates.
- Preliminary study:
- In preliminary tests the doses to be further investigated were found to be 1600 - 2500 mg/kg b.w.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 300 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 426 - <= 1 710
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 340 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 469 - <= 1 750
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 320 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 728 - <= 1 560
- Mortality:
- Lethality occured until day 3 after administration.
- Clinical signs:
- other: The following clinical signs have been observed at the day of administration: decreased spontaneous activity, squatting position, prone / lateral position, irregular breathing, respiratory rales, narrowed palpebral fissure and bristled fur. In higher dose
- Gross pathology:
- The macroscopic examination of the died male and female animals revealed the following cahracteristics:
- blood vessels of the gastrointestinal tract considerably injected
- stomach and small intestine filled with substance remains
- stomach inflated
- clotted blood in small intestine
- urinary bladder filled with brownish-gloomy liquid - Other findings:
- The killed animals at the end of the follow-up period were free of macroskopic visible changes.
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- former R 22
- Conclusions:
- Based on LD50 values of 1340 mg/kg bw in female rats and 1300 mg/kg bw in male rats 2-naphthol was classified as harmful according to the criteria of EC Directive 83/467/CEE.
Based on these values the test item beta-naphthol has to be classified as harmful according to CLP-regulation. - Executive summary:
In an assay according to OECD TG 401 on the acute oral toxicity of beta-naphthol the following values for the LD50 were determined:
For male and female animals: 1320 mg/kg bw (wistar rats)
For male animals: 1300 mg/kg bw (wistar rats)
For female animals: 1340 mg/kg bw (wistar rats)
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 300 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- Version / remarks:
- Commission Directive of 25 April 1984
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- Version 1981.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- traditional method
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Hoe: WISKf (SPF71)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hoechst AG, Kastengrund, SPF Breeding Colony
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 8 - 10 weeks
- Weight at study initiation: Females: 176 - 206 g. Males: 177 to 217 g.
- Fasting period before study: not specified
- Housing: Groups of 5 animals in Makrolon cages (Type 4) on soft wood granulates.
- Diet: Altromin 1324 rat diet ad libitum
- Water: tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24°C
- Humidity (%): 30 - 70%
- Air changes (per hr): air-conditioned rooms, air changes not specified.
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Remarks:
- The test substance was aerosoled in polyethylene glycol 400 / ethanol
- Mass median aerodynamic diameter (MMAD):
- 1.657 µm
- Geometric standard deviation (GSD):
- 2.03
- Remark on MMAD/GSD:
- MMAD was determined for all test concentrations. See attached background information.
- Details on inhalation exposure:
- The exposure camber consisted of a stainless-steel and glass cylinder with a volume of 60L, standing in a vent pipe with a volume of ca. 4 m3. The chambers were tested to confirm they yielded a uniform distribution of aerosols in the breathing zones of the animals.
After passing through an oil separation filter and an absolute filter, air was pumped at a pressure of 4 bar into a special nozzle with a welded-in supply tube for the test substance. The air supply at the nozzle was maintained at 800 L/h by means of an air calibrated rotameter.
The test substance could not be dispersed either in its original state or after micronizing, and was therefore aerolised in polyethylene glycol 400 / ethanol at 50%. It was injected into a nozzle at a constant speed by means of a continuous infusion apparature and then directly in the inhalation chamber (primary aerosol). This application method was chosen, as higher concentrations could be achieved when compared with secondary aerosol technique.
In order to ensure a higher atmospheric humidity, air was passed via a porous stone at a rate of 100 L/h through a 1,000 mL vacuum filter flask filled with water. The moisturized air was then conducted straight into the exposure chamber.
A suction device at the bottom of the exposure chamber drew off the aerosol at a rate of 1,100 L/h through a washing flask filled with water, a cotton-wool filter, a Buehler filter and a calcium chloride flask.
The difference in rate between the introduction of air at 800 L/h through the nozzle and its extraction at 1,100 L/h is necessary to maintain the kinetic energy of the aerosol particles and to ensure a laminar flow of the aerosol from the top to the bottom of the exposure chamber. Additional air enters via the animal cages, but causes no significant dilution of the aerosol. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 0.90, 1.94, 2.50 and 5.06 mg/L (air)
- No. of animals per sex per dose:
- 5 animals/sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Behaviour check were carried out twice daily (once daily during week-end). Animals were weighted on Days 1, 8 and 15.
- Necropsy of survivors performed: yes - Statistics:
- The LC50, 95% limits of confidence and equation of the probit lines were established on the basis of the mortality rates by probit analysis.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 2.2 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- 10/10 exposed to 5.06 mg/L (air) of test substance for 4 hours died as a result of the exposure.
9/10 animals exposed to 2.50 mg/L (air) of test substance for 4 hours died as a result of the exposure.
1/10 animals exposed to 1.94 mg/L (air) of test substance for 4 hours died as a result of the exposure.
0/10 animals exposed to 0.90 mg/L (air) of test substance for 4 hours died as a result of the exposure. - Clinical signs:
- other:
- Body weight:
- Body weight development was impaired during the first week. At the end of the study, all surviving animals had surpassed their initial weights.
- Gross pathology:
- Autopsy of the animals found dead revealed the following changes:
- Lungs discoloured red, dark red and black
- Lungs patchy (red or dark-red)
- Foam or blood coloured liquid escaped after dissection of lungs - Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LC50 of the test item in rats following a 4-hour exposure via the inhalation route was determined to be 2.20 mg/L (air). The test item meets the criteria for classification as Acute Tox. 4; H332 according to Regulation (EC) No.1272/2008 since the value is between 1.0 and 5.0 mg/L.
- Executive summary:
The acute toxicity: inhalation of the test substance was determined in accordance with the OECD Guideline for Testing of Chemicals 403. The study was GLP-compliant.
Groups of 5 male and female Wistar rats were exposed for 4 hours to concentrations of 0.9, 1.94, 2.50, 5.06 mg/L (air) of 2-naphthol. The substance was aerosoled at 50% in polyethylene glycol 400 / ethanol (1:1).
Analysis were conducted during exposure to confirm the actual concentrations the animals were exposed to.
At the end of exposure, animals were observed for 14 days. Bodyweight and clinical signs were recorded. At the end of the observation period, surviving animals were necropsied.
All the animals exposed to the highest concentration of test substance in air were found dead by the end of the observation period. At 2.50 mg/L (air), 9/10 animals died as a result of the exposure. 1/10 animals exposed to 1.94 mg/L (air) of test substance for 4 hours was found dead. All the animals exposed to 0.90 mg/L (air) survived until the end of the observation period.
The animals showed irregular respiration, sonorous rales, panting, gasping, sneezing, narrowed palpebral fissures, stilted, uncoordinated and ataxic gait, ataxia, trembling, decreased spontaneous activity, sunken flanks, squatting posture, prone position, straddling hind limbs, forward crawling, ruffled and bristling coat, blood-coloured encrusted noses, blood coloured nasal discharge, stupor, sedation, reduced or absent pawreflex to pinching, reduced or no placing reflex, delayed or no corneal reflex, corneal opacity and diarrhea.
Body weight development was impaired during the first week. At the end of the study, all surviving animals had surpassed their initial weights.
At necropsy, changes were observed in the lungs of animals.
The 4h-LC50 was determined to be 2.20 mg/L (air) based on the deaths observed during the study. Since this value is between 1.0 and 5.0 mg/L (air), 2-naphthol meets the criteria for classification as Acute Tox. 4; H332 according to Regulation (EC) No.1272/2008.
Reference
See attached background documents
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 2.2 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- the study does not need to be conducted because inhalation of the substance is likely
Reference
Additional information
Justification for classification or non-classification
Following an acute oral toxicity study in rats, it was determined the 2-naphthol had an LD50 value of 1300 mg/kg/bw and is classified as harmful according to Regulation EC No. 1272/2008.
Following an acute inhalation toxicity study in rats, it was determined that 2-naphthol had an LC50 value of 2.2 mg/m3 and meets the criteria for classification as Acute tox. 4 according to Regulation EC No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.